Company Filing History:
Years Active: 2016
Title: Marcel Keller: Innovator in Medicinal Chemistry
Introduction
Marcel Keller is a prominent inventor based in Allschwil, Switzerland, recognized for his significant contributions to the field of medicinal chemistry. With one patent to his name, Keller's work focuses on innovative compounds that hold promise in treating various medical conditions.
Latest Patents
Keller's notable patent includes the invention of 4-(benzoimidazol-2-yl)-thiazole compounds and related aza derivatives. This invention details a series of compounds described by a specific formula, which have been identified for their potential use as pharmaceutical agents, particularly as modulators of the CXCR3 receptor. This advancement presents significant therapeutic applications in the medical field.
Career Highlights
Marcel Keller is associated with Actelion Pharmaceuticals Ltd., a company that specializes in the development of innovative drugs for diseases with high unmet medical needs. His work contributes to the ongoing research efforts at Actelion aimed at creating effective pharmaceutical solutions.
Collaborations
In his professional endeavors, Keller collaborates with esteemed colleagues including Eva Caroff and Thierry Kimmerlin. Their combined expertise fosters a dynamic research environment that drives forward innovative drug development processes.
Conclusion
Marcel Keller's contributions to medicinal chemistry exemplify the impact that dedicated inventors can have on improving healthcare outcomes. With his innovative patent and collaborative spirit, Keller continues to pave the way for future advancements in drug development, demonstrating the vital role of inventors in the scientific community.